ERN ReCONNET
Events & Media
Past and future meetings, conferences, congresses.
News
News from relevant stakeholders on health and rare diseases. Take a look at it and start to engage with the initiatives enlisted here.
If you have a news that you would like us to share, please send us an email to:
ern.reconnet(at)ao-pisa.toscana.it
FESCA event in the EU Parliament
Federation of European Scleroderma Associations (FESCA) held an event in the EU Parliament to present the findings of the patient survey, which highlighted the challenges faced by the Scleroderma community alongside the solutions to addressing these issues. At this roundtable speakers acknowledged the importance of the European References Networks (ERNs) in enhancing access to care,…...
2023 edition of the State of Health in the EU’s Synthesis Report
The Country Health Profiles are accompanied by a Synthesis Report presented by the European Commission, which highlights a selection of horizontal observations based on the analysis of the country profiles. The 2023 edition of the State of Health in the EU’s Synthesis Report consists of two parts. Part 1 presents a chapter on European health systems’ reforms and investments…...
Phenotypic similarity-based approach for variant prioritization for unsolved rare disease: a preliminary methodological report
Interesting scientific article on a prioritization methodology aimed at solving the undiagnosed rare diseases. Here is the abstract for more detailed information and the pdf can be downloaded at the bottom. Rare diseases (RD) have a prevalence of not more than 1/2000 persons in the European population, and are characterised by the difficulty experienced in…...
1st REMEDi4ALL International Drug Repurposing Conference
Join the first international drug repurposing conference “Bridging Boundaries: Innovating, Connecting & Reshaping Drug Repurposing”, #iDR24, co-organised by REMEDi4ALL, Beacon, and MeRIT on 6-7 March 2024 in Barcelona (Spain). REMEDi4ALL is Horizon Europe-funded project which aims at building a sustainable drug repurposing platform in Europe with an approach of co-creation amongst researchers, clinicians and patients.…...
New Sjogren’s Syndrome Disease Coordinator
Congratulations to Prof. Chiara Baldini from AOUP for being elected as our new Disease Coordinator for Sjogren’s Syndrome! Prof. Baldini has been working in Sjögren’s syndrome (SS) research since 1999. The focus of her research was initially SS clinical phenotyping; during her PhD thesis, she investigated the salivary proteomic biomarkers in SS and later she had…...
EURORDIS Awards 2024 Volunteer Award is our ePAG Silvia Aguilera
ERN ReCONNET is proud and happy to annouce that our ePAG Advocate, Silvia Aguilera, has been awarded of the EURORDIS 2024 Volunteer Award. Congratulations from the entire Network! At ERN ReCONNET, Silvia is the ePAG Advocate representing the Antiphospolid Syndrome (APS) and she is also the Chair of the Young ERN ReCONNET Working Group together…...
ern.reconnet(at)ao-pisa.toscana.it
FESCA event in the EU Parliament
Federation of European Scleroderma Associations (FESCA) held an event in the EU Parliament to present the findings of the patient survey, which highlighted the challenges faced by the Scleroderma community alongside the solutions to addressing these issues. At this roundtable speakers acknowledged the importance of the European References Networks (ERNs) in enhancing access to care,…...
2023 edition of the State of Health in the EU’s Synthesis Report
The Country Health Profiles are accompanied by a Synthesis Report presented by the European Commission, which highlights a selection of horizontal observations based on the analysis of the country profiles. The 2023 edition of the State of Health in the EU’s Synthesis Report consists of two parts. Part 1 presents a chapter on European health systems’ reforms and investments…...
Phenotypic similarity-based approach for variant prioritization for unsolved rare disease: a preliminary methodological report
Interesting scientific article on a prioritization methodology aimed at solving the undiagnosed rare diseases. Here is the abstract for more detailed information and the pdf can be downloaded at the bottom. Rare diseases (RD) have a prevalence of not more than 1/2000 persons in the European population, and are characterised by the difficulty experienced in…...
1st REMEDi4ALL International Drug Repurposing Conference
Join the first international drug repurposing conference “Bridging Boundaries: Innovating, Connecting & Reshaping Drug Repurposing”, #iDR24, co-organised by REMEDi4ALL, Beacon, and MeRIT on 6-7 March 2024 in Barcelona (Spain). REMEDi4ALL is Horizon Europe-funded project which aims at building a sustainable drug repurposing platform in Europe with an approach of co-creation amongst researchers, clinicians and patients.…...
New Sjogren’s Syndrome Disease Coordinator
Congratulations to Prof. Chiara Baldini from AOUP for being elected as our new Disease Coordinator for Sjogren’s Syndrome! Prof. Baldini has been working in Sjögren’s syndrome (SS) research since 1999. The focus of her research was initially SS clinical phenotyping; during her PhD thesis, she investigated the salivary proteomic biomarkers in SS and later she had…...
EURORDIS Awards 2024 Volunteer Award is our ePAG Silvia Aguilera
ERN ReCONNET is proud and happy to annouce that our ePAG Advocate, Silvia Aguilera, has been awarded of the EURORDIS 2024 Volunteer Award. Congratulations from the entire Network! At ERN ReCONNET, Silvia is the ePAG Advocate representing the Antiphospolid Syndrome (APS) and she is also the Chair of the Young ERN ReCONNET Working Group together…...
